Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001336
Filing Date
2025-05-15
Accepted
2025-05-15 16:31:12
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20250331x10q.htm   iXBRL 10-Q 1588093
2 EX-31.1 nnvc-20250331xex31d1.htm EX-31.1 10941
3 EX-31.2 nnvc-20250331xex31d2.htm EX-31.2 10857
4 EX-32.1 nnvc-20250331xex32d1.htm EX-32.1 6467
5 EX-32.2 nnvc-20250331xex32d2.htm EX-32.2 6638
  Complete submission text file 0001410578-25-001336.txt   5658772

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20250331.xsd EX-101.SCH 42017
7 EX-101.CAL nnvc-20250331_cal.xml EX-101.CAL 31507
8 EX-101.DEF nnvc-20250331_def.xml EX-101.DEF 171772
9 EX-101.LAB nnvc-20250331_lab.xml EX-101.LAB 321635
10 EX-101.PRE nnvc-20250331_pre.xml EX-101.PRE 236220
66 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20250331x10q_htm.xml XML 840703
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 25954165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)